In addition, we recently reported that a cell-permeable peptide mimicking the kinase-inhibitory region of the suppressor of the cytokine signaling-1 (SOCS1) regulatory protein protects against nephropathy by suppressing STAT-mediated cell responses to diabetic conditions in vitro and in vivo [21]. This evidence concerns the gene SOCS1 and Nephropathy.